Eribulin (Halaven) approved by US FDA
Sea sponge - Halichondria okadai |
- Halaven is a synthetic form of a chemotherapeutically active compound derived from the sea sponge Halichondria okadai. This injectable therapy is a microtubule inhibitor, believed to work by inhibiting cancer cell growth. Before receiving Halaven, patients should have received prior anthracycline- and taxane-based chemotherapy for early or late-stage breast cancer.
US FDA News Release Nov. 15, 2010
0 comments:
Post a Comment